Product Information
NITROFURANTOIN 25 MG/5 ML SUSP is a generic product labeled by Aurobindo Pharma Limited, priced at $1.6860 per ML under NDC 59651020623. Its NADAC has been published 107 times since Sep 18, 2024.
FDA first approved this application on May 11, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/5mL
Manufacturer
Aurobindo Pharma LimitedNDC
59651020623
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NITROFURANTOIN MONOHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA212607FDA Approved
5/11/2023
TE Code
AB
On Market Since
5/11/2023
Pharmacological Classes
Price Statistics
The NADAC for NITROFURANTOIN 25 MG/5 ML SUSP has been published 107 times since Sep 18, 2024, and over the history we have for it it has declined 63.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6860 per ML |
|---|---|
| All-time high | $4.6862 (Nov 13, 2024) |
| All-time low | $1.6860 (Sep 23, 2026) |
| 52-week high | $2.8435 |
| 52-week low | $1.6860 |
| Median price | $2.8435 |
| Average price | $2.8728 |
| Largest weekly change | -16.2% (Nov 20, 2024) |
| Weeks tracked | 107 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nitrofurantoin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitrofuran Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NITROFURANTOIN 25 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for NITROFURANTOIN 25 MG/5 ML SUSP, manufactured by Aurobindo Pharma Limited, is $1.6860 per ML (NDC 59651020623), effective Sep 30, 2026.
How has the price of NITROFURANTOIN 25 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for NITROFURANTOIN 25 MG/5 ML SUSP has declined 63.0%. It has been tracked across 107 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for NITROFURANTOIN 25 MG/5 ML SUSP?
Since Sep 18, 2024, the NADAC for NITROFURANTOIN 25 MG/5 ML SUSP has ranged from a low of $1.6860 (Sep 23, 2026) to a high of $4.6862 (Nov 13, 2024), with a median of $2.8435 per ML.
Are there cheaper alternatives to NITROFURANTOIN 25 MG/5 ML SUSP?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NITROFURANTOIN 25 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures NITROFURANTOIN 25 MG/5 ML SUSP?
NITROFURANTOIN 25 MG/5 ML SUSP (NDC 59651020623) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.